Common use of All Notices Clause in Contracts

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven are mailed or emailed to: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Forty Seven Inc. [*] With a copy to: ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇ All financial invoices to Forty Seven (i.e., accounting contact) are e-mailed to: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ [*] All progress report invoices to Forty Seven (i.e., technical contact) are e-mailed to: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ [*] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 ▇.▇. ▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇ Either party may change its address with written notice to the other party.

Appears in 4 contracts

Sources: Exclusive (Equity) Agreement, Exclusive Agreement (Forty Seven, Inc.), Exclusive Agreement (Forty Seven, Inc.)

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent delivered (with delivery confirmed in writing) as follows: All general notices to Forty Seven Eidos are mailed or emailed to: Eidos Therapeutics, Inc. [*****] With a copy, which shall not constitute notice, to: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇Forty Seven Inc. [*] With a copy to: LLP ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇ All financial invoices to Forty Seven Eidos (i.e., accounting contact) are e-mailed to: ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ [*****] All progress report invoices to Forty Seven Eidos (i.e., technical contact) are e-mailed to: ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ [*****] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [*****] All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 ▇.▇. ▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [******] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇ [*****] Either party may change its address with written notice to the other party.

Appears in 3 contracts

Sources: Exclusive (Equity) Agreement (BridgeBio Pharma, Inc.), Exclusive (Equity) Agreement (BridgeBio Pharma LLC), Exclusive (Equity) Agreement (Eidos Therapeutics, Inc.)

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent delivered (with delivery confirmed in writing) as follows: All general notices to Forty Seven Eidos are mailed or emailed to: Eidos Therapeutics, Inc. [*****] With a copy, which shall not constitute notice, to: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇Forty Seven Inc. [*] With a copy to: LLP ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇ All financial invoices to Forty Seven Eidos (i.e., accounting contact) are e-mailed to: ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ [*****] All progress report invoices to Forty Seven Eidos (i.e., technical contact) are e-mailed to: ▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇▇ [*****] All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [*****] [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 ▇.▇. ▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [******] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇ [*****] Either party may change its address with written notice to the other party.

Appears in 1 contract

Sources: Exclusive (Equity) Agreement

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven AKOYA are mailed or emailed to: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Forty Seven Inc. [*] With a copy to: ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇D▇▇▇▇ ▇▇▇▇▇▇▇▇ & 3▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ d▇▇@▇▇▇▇▇▇▇▇▇▇.▇▇▇ With cc to (which shall not constitute notice): WSGR c/o V▇▇▇ ▇▇▇▇▇▇▇ 6▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ Phone 6▇▇▇▇▇@▇.▇▇▇.▇▇Fax 6▇▇.▇▇▇.▇▇▇▇ S14-157: Execution Copy Exclusive (Equity) Agreement All financial invoices to Forty Seven AKOYA (i.e., accounting contact) are e-mailed to: R▇▇ ▇▇▇▇ 3▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇[*] ▇▇▇▇▇ r▇▇@▇▇▇▇▇▇▇▇▇▇.▇▇▇ All progress report invoices to Forty Seven AKOYA (i.e., technical contact) are e-mailed to: ▇▇▇▇D▇▇▇▇ ▇▇▇▇▇▇▇▇ 3▇▇ [*] ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ d▇▇@▇▇▇▇▇▇▇▇▇▇.▇▇▇ All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing 3▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ i▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 ▇.P.▇. ▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ All progress reports to Stanford are e-mailed or mailed to: Office of Technology Licensing 3▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ i▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to p▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇. Either party may change its address with written notice to the other party.. S14-157: Execution Copy Exclusive (Equity) Agreement

Appears in 1 contract

Sources: Exclusive (Equity) Agreement (Akoya Biosciences, Inc.)

All Notices. All notices under this Agreement are deemed fully given when written, addressed, and sent as follows: All general notices to Forty Seven Eiccose are mailed or emailed to: Eiccose, Inc. Attention: ▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ Forty Seven Inc. [*] With a copy to: ▇▇▇▇ ▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & ▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇ ▇▇▇▇ , ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇ ▇▇▇▇All financial invoices and progress report invoices shall be sent to Eiccose by e-mail to: ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇ All financial invoices to Forty Seven (i.e., accounting contact) are e-mailed to: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ [*] All progress report invoices to Forty Seven (i.e., technical contact) are e-mailed to: ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ [*] . All general notices to Stanford are e-mailed or mailed to: Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ All payments to Stanford are mailed to: Stanford University Office of Technology Licensing Department #44439 ▇.▇. ▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ All progress reports to Stanford are e-mailed or mailed to: [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Office of Technology Licensing ▇▇▇▇ ▇▇ ▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇ ▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇ ▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇ ▇▇▇▇@▇▇▇▇▇▇▇.▇▇▇▇▇▇▇▇.▇▇▇ [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended. Any notice related to Section 7.4 or Section 7.5 (Stanford Purchase Rights) shall be copied concurrently to ▇▇▇▇▇▇▇▇▇▇@▇▇▇▇▇▇▇▇.▇▇▇ Either party may change its address with written notice to the other party.

Appears in 1 contract

Sources: Exclusive Agreement (Celladon Corp)